EGFR-IN-44
EGFR-IN-44 is a potent and orally bioavailable (33.57%) EGFR tyrosine kinase inhibitor with an IC50 of 4.11 nM. It induces apoptosis and is a valuable research tool for studying non-small cell lung cancer in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Molecular Formula
C27H29ClN6O2S
Molecular Weight
537.08
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog